A new standard of care for advanced-stage urothelial carcinoma

Nat Rev Clin Oncol. 2024 May;21(5):336. doi: 10.1038/s41571-024-00884-0.
No abstract available

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Carcinoma, Transitional Cell* / drug therapy
  • Carcinoma, Transitional Cell* / pathology
  • Carcinoma, Transitional Cell* / therapy
  • Humans
  • Neoplasm Staging
  • Standard of Care*
  • Urinary Bladder Neoplasms / drug therapy
  • Urinary Bladder Neoplasms / pathology
  • Urinary Bladder Neoplasms / therapy
  • Urologic Neoplasms / pathology
  • Urologic Neoplasms / therapy